Top FDA vaccine official rejected broad use of Covid-19 shots, documents show

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use of two Covid-19 vaccines, newly released documents show. Read More

US FDA Approves Expanded Use of Moderna's RSV Vaccine for At-Risk Adults - U.S. News & World Report

US FDA Approves Expanded Use of Moderna's RSV Vaccine for At-Risk Adults (Reuters) -The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus ... Read More

FDA Approves Novavax's COVID-19 Vaccine Nuvaxovid - MPR

The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active immunization to prevent COVID-19 caused by SARS-Cov-2 in adults 65 years and older and ... Read More

FDA Approves Novavax COVID Vaccine With Restricted Use - WebMD

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness ... Read More

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - KESQ

Get Breaking News Alerts. CNN – Health. After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk. By CNN Newsource. Published May 17, ... Read More

FDA approves Moderna's next-generation COVID vaccine for adults 65 or older - New York Post

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness. Read More

FDA approves Moderna’s new lower-dose COVID-19 vaccine

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option. Read More

US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults

MARYLAND – The US Food and Drug Administration (FDA) on June 12 expanded the use of Moderna’s respiratory syncytial virus (RSV) vaccine to a younger group of adults aged 18 to 59 who are at ... Read More

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - CNN

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up ... Read More

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - News Channel 3-12

By Katherine Dillinger, CNN (CNN) — After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according ... Read More

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - News-Press NOW

By Katherine Dillinger, CNN (CNN) — After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for ... Read More

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - KTVZ

By Katherine Dillinger, CNN (CNN) — After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for ... Read More